Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer's Q3 Revenues Rise 13 Percent Amid 'Strong Growth' in Gene Screening, Medical Imaging

NEW YORK (GenomeWeb News) — PerkinElmer yesterday reported that third-quarter revenues increased 13 percent as R&D spending jumped 12 percent and profit ticked up about 3 percent.
Total receipts for the three months ended Sept. 30 increased to $435.7 million from $386.9 million year over year, PerkinElmer said. 
Revenue for the company’s Life and Analytical Sciences business and its Optoelectronics unit swelled 13 percent year over year apiece, to $319.3 million and $116.3 million, respectively.
Feeding the increase was “strong growth in genetic screening, medical imaging, and service,” PerkinElmer said.
R&D spending in the quarter increased to $27.7 million from $24.8 million year over year.
PerkinElmer said profits in the period rose to $30.7 million from $29.8 million in the prior-year period.
PerkinElmer said it had around $160.9 million in cash and equivalents as of Sept. 30.
CEO Gregory Summe said in a statement that the company’s “investments in new products, services and geographic expansion continue to yield attractive results.” He did not elaborate in the statement.
The company said it expects fourth-quarter revenue to increase in the mid-teens with acquisitions and changes in foreign exchange rates contributing approximately 7 percent of that growth.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.